» Articles » PMID: 19126249

Identifying Patient-relevant Endpoints Among Individuals with Schizophrenia: an Application of Patient-centered Health Technology Assessment

Overview
Date 2009 Jan 8
PMID 19126249
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Schizophrenia imposes a great burden on society, and while evaluation should play an important role in informing society's efforts to alleviate these burdens, it is unclear what "endpoints" should be chosen as the objective of such analyses. The objectives of the study were to elicit endpoints directly from patients with schizophrenia, to ascertain whether patients are sufficiently cognoscente to express what endpoints are and are not important to them and to rank the relevant endpoints.

Methods: We applied principles of patient-centered health technology assessment to identify and value endpoints from the patient's perspective. Focus groups were conducted to elicit endpoints, using interpretive phenomalogical analysis (IPA) to guide the collection, analysis and interpretation of data. Patient interviews were subsequently used to elicit patient preference over endpoints. Respondents were presented with cards outlining the endpoints and asked to remove irrelevant cards. They where then asked to identify and rank their five most relevant endpoints in order of importance. Interviews were recorded for the purposed of triangulation, and data was analyzed using descriptive statistics. Patients were recruited from five geographically diverse cities in Germany. Eligibility required a diagnosis of schizophrenia by a physician and treatment with an antipsychotic medication for at least one year. Respondents were excluded if they were experiencing an acute episode.

Results: Thirteen endpoints emerged as important from the focus groups spanning side-effects, functional status, processes of care and clinical outcomes. Respondents could clearly identify relevant and irrelevant endpoints, and rank which factors were important to them. Triangulation between field notes of the ranking exercise and recordings confirmed that rankings were not arbitrary, but justified from the respondents' point of view.

Conclusions: Patients with schizophrenia can express preferences over endpoints. Our results show that qualitative methods such as IPA can be used to identify factors, but ranking exercises provide a more robust method for ranking the importance of endpoints. Future research involving patients with schizophrenia ranking outcomes is needed to identify variations across patients and methods such as conjoint analysis could prove beneficial in identifying acceptable tradeoffs across endpoints.

Citing Articles

Using best-worst scaling to inform policy decisions in Africa: a literature review.

Beres L, Campoamor N, Hawthorn R, Mugambi M, Mulabe M, Vhlakis N BMC Public Health. 2024; 24(1):2607.

PMID: 39334072 PMC: 11438065. DOI: 10.1186/s12889-024-20068-w.


Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference study.

Jones B, Ryan M, Cook N, Gutzwiller F Int J Technol Assess Health Care. 2024; 40(1):e30.

PMID: 38695141 PMC: 11569910. DOI: 10.1017/S0266462324000242.


Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling Results.

Bridges J, Goldberg J, Fitzgerald H, Chumki S, Beusterien K, Will O Patient Prefer Adherence. 2023; 17:2545-2555.

PMID: 37849618 PMC: 10578617. DOI: 10.2147/PPA.S419143.


Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.

Huml R, Collyar D, Antonijevic Z, Beckman R, Quek R, Ye J Ther Innov Regul Sci. 2023; 57(6):1136-1147.

PMID: 37615880 DOI: 10.1007/s43441-023-00570-w.


Patients' perspective on supposedly patient-relevant process and outcome parameters: a cross-sectional survey within the 'PRO patients study'.

Kersting C, Hulsmann J, Weckbecker K, Mortsiefer A BMC Health Serv Res. 2022; 22(1):72.

PMID: 35031052 PMC: 8759763. DOI: 10.1186/s12913-021-07437-6.